Advertisement

Topics

Matinas BioPharma Reports 2017 Second Quarter Financial Results And Reaffirms Clinical And Regulatory Strategy To Advance MAT2203 And MAT2501

20:00 EDT 7 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Matinas BioPharma Reports 2017 Second Quarter Financial Results And Reaffirms Clinical And Regulatory Strategy To Advance MAT2203 And MAT2501

NEXT ARTICLE

More From BioPortfolio on "Matinas BioPharma Reports 2017 Second Quarter Financial Results And Reaffirms Clinical And Regulatory Strategy To Advance MAT2203 And MAT2501"

Quick Search
Advertisement